An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

Journal: Science Translational Medicine

Published: 2020-04-29

Affiliations: 10

Authors: 28

Institutions	Authors	Share
The University of North Carolina at Chapel Hill (UNC), United States of America (USA)		0.34
Monroe Carell Jr. Children's Hospital, VU, United States of America (USA)		0.29
Emory University, United States of America (USA)		0.12
Centers for Disease Control and Prevention (CDC), United States of America (USA)		0.11
UNC Lineberger Comprehensive Cancer Center, United States of America (USA)		0.09
Drug Innovation Ventures at Emory, LLC (DRIVE), United States of America (USA)		0.05
Woodruff Health Sciences Center (WHSC), Emory University, United States of America (USA)		0.01

Return

Latest supplement

Nature Index 2021 Asia Pacific

Sustainability, climate-change mitigation, and biomedical science are key areas for future research prowess in the Asia-Pacific region. While COVID-19 travel restrictions have disrupted collaborations between far-flung nations, they have focused attention on vast opportunities for researchers in countries in close proximity and South and southeast Asia to work more closely together on new initiatives.

Access free